Category Archives: Rare diseases

World Rare Disease Day: embracing the rarity of a leap year

In a leap year like the current one, where 29 February takes on a special significance, we are pleased to reaffirm our commitment to the development of innovative therapies for rare diseases. At OLIGOFASTX, we are proud to join in the commemoration of World Rare Disease Day, an iconic date that reminds us of the […]

Hope for patients with Fuchs’ Endothelial Corneal Dystrophy: Innovations in treatment

Today we talk in our blog about another of the rare diseases that the OLIGOFASTX consortium is working on: Fuchs’ Corneal Endothelial Endothelial Dystrophy (FECD). This pathology affects approximately 4% of the population over 40 years of age, and much more women than men. Results from miRNA expression profiling in FECD endothelial cells demonstrates widespread […]

Alström syndrome: a rare disease with many comorbidities and complications

Rare diseases (affecting fewer than 1 in 2,000 people) are an emerging global public health priority. Given their high heterogeneity and the need to provide individualized medicine for small patient populations, they have become a challenge for healthcare systems and biopharmaceutical research. This post is about one of these diseases that affect young children from […]

Cancer cachexia

Cancer cachexia is a complex metabolic syndrome characterized by marked loss of body weight, anorexia, asthenia, sarcopenia, and anemia. It is the most common manifestation of advanced malignant cancer, leading to death. Approximately half of all cancer patients experience cachexia and the prevalence is over 80% in terminally ill patients, with cachexia being responsible for […]

Providing solutions for rare diseases: a priority for the UN

Perhaps the definition is not the most accurate, but in reality a rare disease does nothing more than denominate a pathology that has not yet been studied, analyzed and against which there is, for the time being, no solution. The complexity of the processes to reach social development solutions for the improvement of patients’ quality […]

Retinitis pigmentosa, a genetic vision pathology

Every last Sunday of September is celebrated the International Retinitis Pigmentosa Day, one of the rare and genetic diseases of the retina. Aware of the complications that the disease can bring, from Oligofastx we work together in the research and development of solutions based on the development of oligonucleotides to reach an effective treatment. This […]

Steinert’s myotonic dystrophy: when muscles become unresponsive

Today is International Myotonic Dystrophy Day, a rare disease with no treatment or cure to date. Although Myotonic Dystrophy is not within the Oligofastx project, it is one of the diseases on which Arthex Biotech (Oligofastx partner company) is researching and working to find a therapeutic solution. Specifically, Arthex is developing an experimental RNA-based drug […]